Back To: Home



June 6-7, 2013
European Lab Automation - Hamburg, Germany

June 12-15, 2013

More Events
Name:
Company:
Email:
 
 
 
PerkinElmer

Personalized medicine market exceeds $28 billion
April 2012
SHARING OPTIONS:

NEW YORK—Kalorama Information noted in a recent report that the personalized medicine testing market surpassed $28 billion in 2011. Tests for personalized medicine continue to gain popularity, especially in oncology, where many new medicines come paired with diagnostic assays. The tests are most popular in this area given the need to determine ideal methods of treatment individually and improve survival rates for patients. Tissue tests, such as immunohistochemical stains and in-situ hybridization, that determine which therapy to pursue for cancer treatment are what have been turning personalized medicine into a reality, the report notes. These tests are expected to experience better-than-average IVD industry revenue growth rates in the next five years. Kalorama listed Abbott Diagnostics, Dako and Roche/Ventana Medical as the market leaders in pharmacodiagnostic histology.

Back

cISBIO

Tecan


THermo

eBiosciences

INDIGO

Singulex
CONTACT US
Drug Discovery News
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2013 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.